Semaglutide
GLP-1 receptor agonist with extended half-life. The most-studied incretin analogue in current metabolic research.
Background
Semaglutide is a 31-amino-acid analogue of human GLP-1 with substitutions at positions 8 and 34 that confer DPP-4 resistance and a fatty-acid linker for extended albumin binding.
Research-grade material; each batch is independently verified for identity, purity and safety, with TFA and heavy-metal screening run on every batch.
Certificate of analysis & pricing
Current-batch COA and reseller pricing unlock with catalogue access.
COA hosted on the lab's own site